Interruption of estradiol signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through disruption of the protein phosphorylation pathway in adipose tissues from immature and mature female rats

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 1077-1090

  Enam, Essam ^a   El Sabeway, Faten ^a   Moran, Francisco ^a   Overstreet, James ^a   Lasley, Bill ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipose tissue; AP 1; ERE; Female rats; Kinases; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN METABOLISM; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; AGING; ANIMALS; BENZOQUINONES; BODY WEIGHT; CELL-FREE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRADIOL; FEMALE; LACTAMS, MACROCYCLIC; ORGAN SIZE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; QUINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TIME FACTORS;

EID: 0032055618     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00683-7     Document Type: Article

References (62)

1. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons Examination of the mechanism of toxicity . Annu Rev Pharmacol Toxicol. 22:1982;517-524.
2. Safe S. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu Rev Pharmacol Toxicol. 26:1986;371-399.
3. Enan E., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced alterations in protein phosphorylation in guinea pig adipose tissue. J Biochem Toxicol. 8:1993;89-99.
4. Enan E., Matsumura F. Significance of TCDD-induced changes in protein phosphorylation in the adipocyte of male guinea pigs. J Biochem Toxicol. 9:1994;159-170.
5. Enan E., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in glucose transporting activity in guinea pigs, mice, and rats in vivo and in vitro. J Biochem Toxicol. 9:1994;97-106.
6. Enan E., Matsumura F. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions . Biochem Pharmacol. 49:1995;249-261.
7. Enan E., Matsumura F. Regulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of the DNA binding activity of transcriptional factors via nuclear protein phosphorylation in guinea pig adipose tissue. Biochem Pharmacol. 50:1995;1199-1206.
8. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol. 52:1996;1599-1612.
9. Enan E., Overstreet J., Matsumura F., Lasley B. Gender differences in the mechanism of dioxin toxicity in rodents and in nonhuman primates. Reprod Toxicol. 10:1996;401-411.
10. Enan E., Moran F., VandeVoort C.A., Stewart D.R., Overstreet J.W., Lasley B.L. Mechanism of toxic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in cultured human luteinizing granulosa cells. Reprod Toxicol. 10:1996;497-508.
11. Enan E., Lasley B., Stewart D., Overstreet J., Vandevoort C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates function of human luteinizing granulosa cells via cAMP signaling and early reduction of glucose transporting activity. Reprod Toxicol. 10:1996;191-198.
12. Whitlock J.P. Jr. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol. 30:1990;251-277.
13. Reyes H., Reisz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science. 256:1992;1193-1195.
14. Whitelaw M., Pongratz I., Wilhelmsson A., Gustafsson J-Å, Poellinger L. Ligand-dependent recruitment of the Arnt coregulator determines DNA recognition by the dioxin receptor. Mol Cell Biol. 13:1993;2504-2514.
15. Denison M.S., Fisher J.M., Whitlock J.P. Jr. The DNA recognition site for the dioxin-Ah receptor complex Nucleotide sequence and functional analysis . J Biol Chem. 263:1988;17221-17224.
16. Heuman D.M., Gallagher E.J., Barwick J.L., Elshourbagy N.A., Guzelian P.S. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16α-carbonitrile or other steroidal or non-steroidal agents. Mol Pharmacol. 21:1982;753-760.
17. Schuetz E.G., Wrighton S.A., Barwick J.L., Guzelian P.S. Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16α-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivo. J Biol Chem. 259:1984;1999-2006.
18. Meek D.W., Street A.J. Nuclear protein phosphorylation and growth control. Biochem J. 287:1992;1-15.
19. O'Malley B.W., Buller R.E. Mechanism of steroid hormone action. J Invest Dermatol. 68:1977;1-4.
20. Katzenellenbogen B.S., Norman M.J. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells Interrelationships among insulin/insulin-like growth factor-1, serum and estrogen. Endocrinology. 126:1990;891-898.
21. Mukku V.R., Stancel G.M. Regulation of epidermal growth factor by estrogen. J Biol Chem. 260:1985;9820-9824.
22. Dickson R.B., Lippman M.E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev. 8:1987;29-43.
23. Ignar-Trowbridge D.M., Pimentel M., Parker M.G., McLachlan J.A., Korach K.S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independent of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
24. Ignar-Trowbridge D.M., Nelson K.G., Bidwell M.C., Curtis S.W., Washburn T.F., McLachlan J.A., Korach K.S. Coupling of dual signaling pathways EGF action involves the estrogen receptor. Proc Natl Acad Sci USA. 89:1992;4658-4662.
25. Vignon F., Bouton M.M., Rochefort H. Antiestrogens inhibit the mitogenic effect of growth factors in breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun. 146:1987;1502-1508.
26. Aronica S.M., Katzenellenbogen B.S. Progesterone receptor regulation in uterine cells Stimulation by estradiol, cyclic adenosine 3′,5′-monophosphate and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors . Endocrinology. 128:1991;2045-2052.
27. Smith D.F., Toft D.O. Steroid receptors and their associated proteins. Mol Endocrinol. 7:1993;4-11.
28. Denton R.R., Koszewski N.J., Notides A.C. Estrogen receptor phosphorylation. Hormonal dependence and consequence on specific DNA binding. J Biol Chem. 267:1992;7263-7268.
29. Castoria G., Migliaccio A., Green S., Di Domenico M., Chambon P., Auricchio F. Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry. 32:1993;1740-1750.
30. Weisz A., Rosales R. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res. 18:1990;5097-5106.
31. Boettger-Tong H.L., Murthy L., Stancel G.M. Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod. 53:1995;1398-1406.
32. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol. 2:1988;816-824.
33. Loose-Mitchell D.S., Chiappetta C., Stancel G. Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol. 2:1988;946-951.
34. Astroff B., Eldridge B., Safe S. Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular proto-oncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus. Toxicol Lett. 56:1991;305-315.
35. Wilding G., Lippman M.E., Gelmann E.P. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res. 48:1988;802-805.
36. Webb D.K., Moulton B.C., Khan S.A. Estrogen induced expression of the c-jun proto-oncogene in the immature and mature rat uterus. Biochem Biophys Res Commun. 168:1990;721-726.
37. Weisz A., Cicatiello L., Persico E., Scalona M., Bresciani F. Estrogen stimulates transcription of c-jun protooncogene. Mol Endocrinol. 4:1990;1041-1050.
38. Dignam I.D., Lebouitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
39. Yamaki H., Nakajima M., Seimiya H., Saya H., Sugita M., Tsuruo T. Inhibition of the association, with nuclear matrix of pRB, p70 and p40 proteins along with the specific suppression of c-MYC expression by geldanamycin, an inhibitor of Src tyrosine kinase. J Antibiot (Tokyo). 48:1995;1021-1026.
40. Reddy K.B., Mangold G.L., Tandon A.K., Mundy G.R., Zilberstein A., Osborne C.K. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Cancer Res. 52:1992;3636-3641.
41. Monti E., Sinha B.K. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines. Anticancer Res. 14:1994;1221-1226.
42. Clark J.W., Santos-Moore A., Stevenson L.E., Frackelton A.R. Jr. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the Ras signaling pathway. Int J Cancer. 65:1996;186-191.
43. Northwood I.C., Davis R.J. Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization. J Biol Chem. 263:1988;7450-7453.
44. Moudgil V.K. Phosphorylation of steroid hormone receptors. Biochim Biophys Acta. 1055:1990;243-258.
45. Hoeck W., Rusconi S., Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J Biol Chem. 264:1989;14396-14402.
46. Orti D., Bodwell J.E., Munck A. Phosphorylation of steroid hormone receptors. Endocr Rev. 13:1992;105-128.
47. Green S., Walter P., Kumar V., Krust A., Bornet J-M, Argos P., Chambon P. Human oestrogen receptor cDNA Sequence, expression and homology to v-erb-A. Nature. 320:1986;134-139.
48. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 270:1995;1491-1494.
49. Ham J., Parker M.G. Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol. 1:1989;503-511.
50. Lamb P., McKnight S.L. Diversity and specificity in transcriptional regulation The benefits of heterotypic dimerization . Trends Biochem Sci. 16:1991;417-422.
51. Miner J.N., Yamamoto K.R. Regulatory crosstalk at composite response elements. Trends Biochem Sci. 16:1991;423-426.
52. Wagner S., Green M.R. Retinoblastoma. A transcriptional tryst. Nature. 352:1991;189-190.
53. Romkes M., Piskorska-Pliszczynska J., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels in rats. Toxicol Appl Pharmacol. 87:1987;306-314.
54. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., Humiston C.G. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46:1978;279-303.
55. Gallo M.A., Hesse E.J., MacDonald G.J., Umbreit T.H. Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic cytochrome P450 and mouse uterus. Toxicol Lett. 32:1986;123-132.
56. Romkes M., Safe S. Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in the female rat uterus. Toxicol Appl Pharmacol. 92:1988;368-380.
57. Astroff B., Safe S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as an antiestrogen Effect on rat uterine peroxidase activity . Biochem Pharmacol. 39:1990;485-488.
58. Zacharewski T., Harris M., Safe S. Evidence for a possible mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant Hepa 1c1c7 cells. Biochem Pharmacol. 41:1991;1931-1939.
59. Harris M., Zacharewski T., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells. Cancer Res. 50:1990;3579-3584.
60. Gierthy J.F., Lincoln D.W. Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res Treat. 12:1988;227-233.
61. Spink D.C., Lincoln D.W. II, Dickerman H.W., Gierthy J.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci USA. 87:1990;6917-6921.
62. Biegel L., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. J Steroid Biochem Mol Biol. 37:1990;725-732.